MS

Miklos Stanek

Founding Partner at BackBone Ventures

Zurich, Zurich

VC
Investor

Invests in

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $2,500,000.00

Skills

Co-Creation
Start-up-Unternehmen
Software as a Service (SaaS)
Investitionen
Kommunikation
Vertrieb
Risikokapital
Start-ups
Leadership
Management
Sales
Teamwork
Unternehmensstrategie
Geschäftsführung
Partnermanagement
Triathlon
Startup-Entwicklung
Kundendienst

Education

  • ETH Zürich

    (2006 - 2007)

  • Zertifizierter Verwaltungsrat AKAD

    AKAD

    (2016 - 2017)

  • Eidgenössische Matur

    Gymnasium Neufeld

    (2005 - 2006)

Investments

Neon

Convertible Note

Total Funding: $830M

ImmunOs Therapeutics

Pre Seed

Total Funding: $88M

Work Experience

Creaitor

2024

  • Investor

    2024

Aepsy

2022

  • Investor

    2022

findependent

2022

  • Board Member

    2022

    Roboadvisor

CareerFairy

2021

  • Board Observer

    2021

The Singularity Group

2019

  • Investor

    2019

Threatray

2018

  • Investor

    2018

BackBone Ventures

2018

  • Founding Partner & Chairman

    2018

    Currently we invest out of our 5502 Fund, which focuses on backing underrepresented founders in Germany & Switzerland at the earliest stages of their entrepreneurial journey. We are generalists and happy to take the lead in your financing round.

neon

2019

  • Board Member

    2019

ImmunOs Therapeutics AG

2014

  • Investor

    2014

Aquilas Company Builder AG

2016 - 2018

  • Co-Founder

    2016 - 2018